For the Inventor, By the Inventor

Enter assignee name

Gaithersburg, MD, United States of America

Genvec, Inc.

USPTO Granted Patents = 88

CIPO Patents = 4

EPO Patents = 17

Forward Citations = 1,762

Loading Chart...

Loading Chart...

43 inventors (with patents filed for the assignee):

Douglas E Brough (54 out of 58 patents)

Imre Kovesdi (54 out of 58 patents)

Duncan L McVey (37 out of 41 patents)

4. Joseph T Bruder (21 out of 25 patents)

5. Jason G D Gall (18 out of 20 patents)

6. Thomas J Wickham (18 out of 19 patents)

7. Petrus W Roelvink (10 out of 12 patents)

8. C Richter King (8 out of 24 patents)

9. Lisa Wei (5 out of 5 patents)

10. Jason Gall (5 out of 8 patents)

11. Alena Lizonova (5 out of 5 patents)

12. Marilyn Menger (5 out of 5 patents)

13. Damodar R Ettyreddy (4 out of 6 patents)

14. Ping Chen (4 out of 4 patents)

15. Miguel E Carrión (4 out of 4 patents)

Core Competencies:

Adenoviral Vectors

Gene Transfer

Malaria Vaccines

Cancer Therapy

Herpes Simplex Virus Vaccine

RSV Vaccine

Dengue Fever Vaccine

Chimeric Vectors

Transgene Persistence

Neovascularization Modulation

Adenoviral Capsid

Adenoviral Vector Systems

88 patents: Sort by Forward Citations

1. 11359214 - Simian (gorilla) adenovirus or adenoviral vectors and methods of use (2022-06-14),

2. 11279951 - Adenoviral vector encoding human atonal homolog-1 (HATH1) (2022-03-22),

3. 11155832 - Adenovectors for delivery of therapeutic genetic material into T cells (2021-10-26),

4. 11034975 - Affenadenovirus (gorilla) or adenoviral vectors and methods of use (2021-06-15),

5. 10947560 - Modified serotype 28 adenoviral vectors (2021-03-16),

6. 10792376 - Affenadenovirus (gorilla) or adenoviral vectors and methods of use (2020-10-06),

7. 10787682 - Simian (gorilla) adenovirus or adenoviral vectors and methods of use (2020-09-29),

8. 10780153 - Malaria antigens and methods of use (2020-09-22),

9. 10640776 - Method for propagating adenoviral vectors encoding inhibitory gene products (2020-05-05),

10. 10314901 - Malaria antigens and methods of use (2019-06-11),

11. 10272162 - Affenadenovirus (gorilla) or adenoviral vectors and methods of use (2019-04-30),

12. 10260074 - Affenadenovirus (gorilla) or adenoviral vectors and methods of use (2019-04-16),

13. 10125174 - Herpes simplex virus vaccine (2018-11-13),

14. 10059962 - Simian (gorilla) adenovirus or adenoviral vectors and methods of use (2018-08-28),

15. 10022432 - Malaria antigens and methods of use (2018-07-17),

GenVec, Inc. is a biopharmaceutical company focused on developing unique gene-based therapeutics and vaccines. With expertise in adenoviral vectors and proprietary cell lines, GenVec aims to create innovative treatments for diseases with significant unmet medical needs. The company's mission is to improve patient outcomes through the advancement of gene therapies and vaccine development.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

88 Patents

#3 in Gaithersburg, MD

#35 in Maryland

#4,090 in US

#8,438 in the World

Gaithersburg, MD, United States of America

Genvec, Inc.

Forward Citations = 1,762

43 inventors:

Douglas E Brough (54 out of 58 patents)

Imre Kovesdi (54 out of 58 patents)

Duncan L McVey (37 out of 41 patents)

4. Joseph T Bruder (21 out of 25 patents)

5. Jason G D Gall (18 out of 20 patents)

Please report any incorrect information to support@idiyas.com

Loading…